GlassScriptPhysician profile
Denecia Michelle Lewis
NPI 1861127904
$3,758.72
in general payments reported to CMS, 2019-2025
18 companies · $619 in 2025
The $619 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,600 · 2023: $854 · 2024: $686 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,551.44 | 2022-2024 | Axonics |
| Medtronic, INC. | $319.82 | 2022-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $268.50 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $262.12 | 2023 | Urolift |
| Boston Scientific Corporation | $245.86 | 2024-2025 | Ams 700, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $227.48 | 2022-2024 | |
| Procept Biorobotics Corporation | $207.95 | 2025 | |
| Bluewind Medical | $205.31 | 2024-2025 | Revi |
| Avation Medical, INC. | $117.50 | 2024 | Vivally |
| Valencia Technologies Corporation | $88.51 | 2022-2025 | Ecoin Device Kit |
| Janssen Biotech, INC. | $61.43 | 2024 | Erleada |
| Myovant Sciences INC. | $42.57 | 2022 | |
| Ferring Pharmaceuticals INC. | $42.51 | 2024 | Adstiladrin |
| Merck Sharp & Dohme LLC | $37.62 | 2022-2024 | Lynparza |
| Antares Pharma, INC. | $27.60 | 2022-2023 | Nocdurna, Xyosted, Tlando |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $22.87 | 2023 | Altis |
| Olympus America INC. | $16.09 | 2024 | Itind System |
| Astrazeneca Pharmaceuticals LP | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denecia Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.